Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-26

Clinical Trial Update: ICG Fluorescence Guided Lymph Node Mapping for Determination of Bowel Resection Margins in Colon Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluated indocyanine green (ICG) fluorescence guidance to map lymph nodes for determining bowel resection margins in colon cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: N.N. Petrov National Medical Research Center of Oncology | Conditions: Colon Cancer | NA | Status: COMPLETED